Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | VP, Finance and CAO | May 01, 2017 | May 04, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 01, 2017 · Filed May 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,478 |
Reported balance
After 2017-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-05-01 · Grant · Acquired 615 · Balance 8,478 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 99 RSUs which vest on 4/25/2018; 1,334 RSUs which vest in one installment of 657 on 8/1/2017 and one installment of 677 on 8/1/2018; 191 RSUs which vest in one installment of 94 on 4/24/2018 and one installment of 97 on 4/24/2019; 798 RSUs which vest in one installment of 393 on 4/24/2018 and one installment of 405 on 4/24/2019; 575 RSUs which vest in installments of 189 on 5/3/2018, 190 on 5/3/2019 and 196 on 5/3/2020; and 615 RSUs which vest in installments of 202 on 5/1/2019, 203 on 5/1/2020 and 210 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 156 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $162.60 · Expires 2027-05-01 | Direct | 5,446 |
Reported balance
After 2017-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-01 · Grant · Acquired 5,446 · Balance 5,446 F4: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 99 RSUs which vest on 4/25/2018; 1,334 RSUs which vest in one installment of 657 on 8/1/2017 and one installment of 677 on 8/1/2018; 191 RSUs which vest in one installment of 94 on 4/24/2018 and one installment of 97 on 4/24/2019; 798 RSUs which vest in one installment of 393 on 4/24/2018 and one installment of 405 on 4/24/2019; 575 RSUs which vest in installments of 189 on 5/3/2018, 190 on 5/3/2019 and 196 on 5/3/2020; and 615 RSUs which vest in installments of 202 on 5/1/2019, 203 on 5/1/2020 and 210 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 156 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount.
F4: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2017 Filed May 4, 2017 01:02 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,446 | $0.00 Strike: $162.60 | $0.00 |
DisclosureSEC source: 0001127602-17-016761 · form4.xml · derivative · entry 2 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,446 Underlying: Common Stock · 5,446 shares Expires 2027-05-01 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. Read SEC document |
| May 01, 2017 Filed May 4, 2017 01:02 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 615 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016761 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,478 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 99 RSUs which vest on 4/25/2018; 1,334 RSUs which vest in one installment of 657 on 8/1/2017 and one installment of 677 on 8/1/2018; 191 RSUs which vest in one installment of 94 on 4/24/2018 and one installment of 97 on 4/24/2019; 798 RSUs which vest in one installment of 393 on 4/24/2018 and one installment of 405 on 4/24/2019; 575 RSUs which vest in installments of 189 on 5/3/2018, 190 on 5/3/2019 and 196 on 5/3/2020; and 615 RSUs which vest in installments of 202 on 5/1/2019, 203 on 5/1/2020 and 210 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 156 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| April 26, 2017 Filed Apr 27, 2017 00:12 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 44 | $164.70 | $7,246.80 |
DisclosureSEC source: 0001127602-17-015594 · form4.xml · nonDerivative · entry 2 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,863 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 99 RSUs which vest on 4/25/2018; 1,334 RSUs which vest in one installment of 657 on 8/1/2017 and one installment of 677 on 8/1/2018; 191 RSUs which vest in one installment of 94 on 4/24/2018 and one installment of 97 on 4/24/2019; 798 RSUs which vest in one installment of 393 on 4/24/2018 and one installment of 405 on 4/24/2019; and 575 RSUs which vest in installments of 189 on 5/3/2018, 190 on 5/3/2019 and 196 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 156 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 00:12 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 40 | $163.14 | $6,525.60 |
DisclosureSEC source: 0001127602-17-015594 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,907 Read SEC document |
| April 24, 2017 Filed Apr 26, 2017 00:22 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 156 | $160.41 | $25,023.96 |
DisclosureSEC source: 0001127602-17-015475 · form4.xml · nonDerivative · entry 2 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,947 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 104 RSUs which vest on 4/26/2017; 195 RSUs which vest in one installment of 96 on 4/25/2017 and one installment of 99 on 4/25/2018; 1,334 RSUs which vest in one installment of 657 on 8/1/2017 and one installment of 677 on 8/1/2018; 191 RSUs which vest in one installment of 94 on 4/24/2018 and one installment of 97 on 4/24/2019; 798 RSUs which vest in one installment of 393 on 4/24/2018 and one installment of 405 on 4/24/2019; and 575 RSUs which vest in installments of 189 on 5/3/2018, 190 on 5/3/2019 and 196 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 171 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| April 24, 2017 Filed Apr 26, 2017 00:22 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 38 | $160.41 | $6,095.58 |
DisclosureSEC source: 0001127602-17-015475 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,103 Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 23:05 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 533 | $166.04 | $88,499.32 |
DisclosureSEC source: 0001127602-17-013101 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,141 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 104 RSUs which vest on 4/26/2017; 195 RSUs which vest in one installment of 96 on 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in two equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in two equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 194 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 22:25 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011108 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,640 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 104 RSUs which vest on 4/26/2017; 195 RSUs which vest in one installment of 96 on 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in two equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in two equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 169 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| August 02, 2016 Filed Aug 4, 2016 00:14 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,000 | $174.59 | $523,758.00 |
DisclosureSEC source: 0001127602-16-059443 · form4.xml · nonDerivative · entry 2 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,183 Read SEC document |
| August 01, 2016 Filed Aug 4, 2016 00:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 258 | $172.03 | $44,383.74 |
DisclosureSEC source: 0001127602-16-059443 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,183 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 104 RSUs which vest on 4/26/2017; 195 RSUs which vest in one installment of 96 on 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in two equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in two equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 120 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| May 03, 2016 Filed May 6, 2016 00:40 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 4,900 | $0.00 Strike: $156.35 | $0.00 |
DisclosureSEC source: 0001127602-16-051296 · form4.xml · derivative · entry 2 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 Underlying: Common Stock · 4,900 shares Expires 2026-05-03 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively. Read SEC document |
| May 03, 2016 Filed May 6, 2016 00:40 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 575 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-051296 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,414 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 104 RSUs which vest on 4/26/2017; 195 RSUs which vest in one installment of 96 on 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in 2 equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; 1,191 RSUs which vest in 2 equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019; and 575 RSUs which vest in installments of 189 on 5/3/2018, 190 on 5/3/2019 and 196 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 120 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| April 26, 2016 Filed Apr 29, 2016 00:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 41 | $163.46 | $6,701.86 |
DisclosureSEC source: 0001127602-16-050229 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,839 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 104 RSUs which vest on 4/26/2017; 195 RSUs which vest in one installment of 96 on 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in 2 equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in 2 equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 120 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| April 25, 2016 Filed Apr 26, 2016 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 39 | $163.19 | $6,364.41 |
DisclosureSEC source: 0001127602-16-049946 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,880 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 205 RSUs which vest in two installments of 101 and 104 on 4/26/2016 and 4/26/2017, respectively; 195 RSUs which vest in one installment of 96 on 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in 2 equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in 2 equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 125 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| March 25, 2016 Filed Mar 29, 2016 21:30 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 729 | $149.24 | $108,795.96 |
DisclosureSEC source: 0001127602-16-047741 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,919 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 205 RSUs which vest in two installments of 101 and 104 on 4/26/2016 and 4/26/2017, respectively; 291 RSUs which vest in two equal installments of 96 on 4/25/2016 and 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in 2 equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in 2 equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares fo the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 128 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| March 02, 2016 Filed Mar 4, 2016 23:24 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-045133 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,607 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 205 RSUs which vest in two installments of 101 and 104 on 4/26/2016 and 4/26/2017, respectively; 291 RSUs which vest in two equal installments of 96 on 4/25/2016 and 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in 2 equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in 2 equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares fo the Companys common stock on a one-to-one basis. F2 · balance_after: These shares include 100 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| July 31, 2015 Filed Aug 4, 2015 22:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,631 | $171.69 | $280,026.39 |
DisclosureSEC source: 0001127602-15-024178 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,641 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 205 RSUs which vest in two installments of 101 and 104 on 4/26/2016 and 4/26/2017, respectively; 291 RSUs which vest in two equal installments of 96 on 4/25/2016 and 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in 2 equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in 2 equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares fo the Companys common stock on a one-to-one basis. F2 · balance_after: These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| April 26, 2015 Filed Apr 29, 2015 00:16 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 40 | $167.91 | $6,716.40 |
DisclosureSEC source: 0001127602-15-015488 · form4.xml · nonDerivative · entry 3 Such Annette Louise · CIK 0001635760 · CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,230 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,080 RSUs which vest fully on 7/31/2015; 205 RSUs which vest in two installments of 101 and 104 on 4/26/2016 and 4/26/2017, respectively; 291 RSUs which vest in two equal installments of 96 on 4/25/2016 and 4/25/2017 and one installment of 99 on 4/25/2018; 1,991 RSUs which vest in two equal installments of 657 on 8/1/2016 and 8/1/2017 and one installment of 677 on 8/1/2018; 285 RSUs which vest in 2 equal installments of 94 on 4/24/2017 and 4/24/2018 and one installment of 97 on 4/24/2019; and 1,191 RSUs which vest in 2 equal installments of 393 on 4/24/2017 and 4/24/2018 and one installment of 405 on 4/24/2019. Vested RSUs will be paid in shares fo the Companys common stock on a one-to-one basis. F3 · balance_after: These shares include 247 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. Read SEC document |
| April 24, 2015 Filed Apr 29, 2015 00:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-015488 · form4.xml · nonDerivative · entry 2 Such Annette Louise · CIK 0001635760 · CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,270 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/24/2017, 4/24/2018 and 4/24/2019, respectively. Read SEC document |
| April 24, 2015 Filed Apr 29, 2015 00:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 285 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-015488 · form4.xml · nonDerivative · entry 1 Such Annette Louise · CIK 0001635760 · CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,079 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/24/2017, 4/24/2018 and 4/24/2019, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.